Therapy News and Research

RSS

Researchers discover that spin flips happen in only half a picosecond in the course of a chemical reaction

Solar cells, quantum computing and photodynamic cancer therapy. These all involve molecules switching between magnetic and nonmagnetic forms.

17 Jan 2019

FDA approves generic drug for treating focal seizures

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.

16 Jan 2019

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, today announced the appointment of Dr Darrell Sleep as Director of Innovation.

From Charles River 16 Jan 2019

Breast cancer cells in mice coaxed to turn into harmless fat cells

As cancer cells respond to cues in their microenvironment, they can enter a highly plastic state in which they are susceptible to transdifferentiation into a different type of cell.

16 Jan 2019

Truncal mutations study suggests new direction in origins of cancer

Cancers most commonly arise because of a series of two to five mutations in different genes that combine to cause a tumor.

16 Jan 2019

Researchers identify comprehensive guidelines for managing severe atopic dermatitis

A team of investigators from the University of Colorado College of Nursing at CU Anschutz Medical Campus and National Jewish Health has identified comprehensive guidelines for managing severe atopic dermatitis (AD), the most common form of eczema.

16 Jan 2019

Research reveals novel approach to suppressing chemotherapy-induced tumor growth

Following up on a groundbreaking 2018 study in which BIDMC's Dipak Panigrahy, MD, demonstrated that dead and dying cancer cells killed by conventional cancer treatments paradoxically trigger inflammation that promotes tumor growth and metastasis, a new study led by Allison Gartung, PhD, describes a novel approach to suppressing chemotherapy-induced tumor growth in an ovarian cancer model.

16 Jan 2019

Changes in hippocampal structural connectivity differentiate responders of electroconvulsive therapy

A new study in people with major depression reports that electroconvulsive therapy induces changes in the fibers connecting the hippocampus to brain regions involved in mood and emotion.

16 Jan 2019

Research finds how Candida albicans adapt to low oxygen levels to cause infection

Scientists from Umeå university have shown how the yeast Candida albicans can modulate and adapt to low oxygen levels in different body niches to cause infection and to harm the host.

16 Jan 2019

MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly's TriNKET™ immunotherapy drug candidates to patients in clinical trials beginning in 2019.

16 Jan 2019

FDA-approved drug hampers cancer metastasis in animal model, shows study

For cancer to spread, it needs a hospitable environment in distant organs. This fertile "soil" can provide a home to circulating malignant cells.

16 Jan 2019

Researchers find how GREB1 gene promotes resistance to prostate cancer treatments

Researchers have discovered how a gene involved in regulating hormone receptors may contribute to drug resistance in some prostate cancer patients.

16 Jan 2019

Multiple sclerosis could benefit from stem cell therapy

Patients with relapsing multiple sclerosis (MS) have benefited from an experimental stem cell therapy. MS is an autoimmune disease where the central nervous system is affected. It is severely debilitating and means a slow and progressive death for the patients.

16 Jan 2019

Study points to potential new biomarker and drug target for amyotrophic lateral sclerosis

Research led by stem cell scientists at Harvard University points to a potential new biomarker and drug target for amyotrophic lateral sclerosis, a neurological disease that is extremely difficult to diagnose and treat.

16 Jan 2019

Nerve transfer surgery restores arm movement in children with acute flaccid myelitis

An innovative and complex surgery involving nerve transfers is restoring hope and transforming lives torn apart by a mysterious and devastating illness. Acute flaccid myelitis, also known as AFM, strikes without warning, shows no mercy and frequently results in paralysis.

15 Jan 2019

Scientists create comprehensive new method to predict breast cancer risk

Scientists have created the most comprehensive method yet to predict a woman's risk of breast cancer, according to a study by Cancer Research UK published in Genetics in Medicine.

14 Jan 2019

Synthetic compound reverses mutant p53 aggregate accumulation, study shows

Cancer is a multidisciplinary disease, with different mutations leading to different prognoses and treatment necessities. Among the most important mutation targets in cancers, affecting more than 50% of all cancer cases, is TP53.

14 Jan 2019

Differences in geographic origin of genes may affect mitochondrial function

Differences in the geographic origin of genes may affect the function of human mitochondria--energy-generating organelles inside of cells--according to a new study.

14 Jan 2019

Researchers identify multiple new subtypes of most common childhood cancer

Like cartographers completing a map, investigators have identified multiple new subtypes of the most common childhood cancer--research that will likely improve the diagnosis and treatment of high-risk patients.

14 Jan 2019

Molecular hallmarks of tumor hypoxia across 19 cancer types discovered

Unlike healthy tissues, tumors thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despite being a well-known cause of therapy resistance and metastasis, the impact of low oxygen, known as hypoxia, on tumor cells is poorly understood.

14 Jan 2019

Therapy News and Research

Researchers discover that spin flips happen in only half a picosecond in the course of a chemical reaction

FDA approves generic drug for treating focal seizures

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Breast cancer cells in mice coaxed to turn into harmless fat cells

Truncal mutations study suggests new direction in origins of cancer

Researchers identify comprehensive guidelines for managing severe atopic dermatitis

Research reveals novel approach to suppressing chemotherapy-induced tumor growth

Changes in hippocampal structural connectivity differentiate responders of electroconvulsive therapy

Research finds how Candida albicans adapt to low oxygen levels to cause infection

MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

FDA-approved drug hampers cancer metastasis in animal model, shows study

Researchers find how GREB1 gene promotes resistance to prostate cancer treatments

Multiple sclerosis could benefit from stem cell therapy

Study points to potential new biomarker and drug target for amyotrophic lateral sclerosis

Nerve transfer surgery restores arm movement in children with acute flaccid myelitis

Scientists create comprehensive new method to predict breast cancer risk

Synthetic compound reverses mutant p53 aggregate accumulation, study shows

Differences in geographic origin of genes may affect mitochondrial function

Researchers identify multiple new subtypes of most common childhood cancer

Molecular hallmarks of tumor hypoxia across 19 cancer types discovered

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News